Concepedia

Jaafar N. Haidar

JN

12

Publications

542

Citations

11

H-Index

2001

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Massachusetts Chan Medical School

Boston University

Harvard University

Massachusetts General Hospital

Jaafar N. Haidar is an author at Eli Lilly (United States) specializing in immunology, autoimmunity, and immunotherapy.

Top concepts

Publications per year

2001–2022

12

Publications

12

Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen

Andrew J. Poole, V. Karuppiah, Annabelle Hartt et al. · Nature Communications · 2022 · 92 citations · Full text

Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors<sup>1</sup>

Daniel C. Danila, Jaafar N. Haidar, Xun Zhang et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 84 citations · Full text

Structure‐based design of a T‐cell receptor leads to nearly 100‐fold improvement in binding affinity for pepMHC

Jaafar N. Haidar, Brian G. Pierce, Yong Yu et al. · Proteins Structure Function and Bioinformatics · 2008 · 72 citations · Full text

Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

Helen Kotanides, Yiwen Li, Maria Malabunga et al. · Cancer Immunology Research · 2020 · 68 citations

Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance

Atrish Bagchi, Jaafar N. Haidar, Scott W. Eastman et al. · Molecular Cancer Therapeutics · 2017 · 55 citations

Rows per page

1–5 of 12